Tata Trusts' IHF backs startup that built low cost test to determine drug resistant TB - Economic Times

HealSeq is incubated at the India Institute of Science (IISc) innovation – Bangalore in March 2020. The start-up works on biomarker discovery, precision medicine and immune profiling.

Mumbai: India Health Fund (IHF), a collaborative initiative of Tata Trusts and The Global Fund to fight AIDS, Tuberculosis and Malaria on Thursday said it will support HealSeq's biomarker-based blood… [+3094 chars]

full article...